These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 8419396

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.
    Sakamoto T, Ishibashi T, Kimura H, Yoshikawa H, Spee C, Harris MS, Hinton DR, Ryan SJ.
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1076-83. PubMed ID: 7537258
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures.
    Chen C, Li J, Micko CJ, Pierce GF, Cunningham MR, Lumsden AB.
    J Surg Res; 1998 Feb 15; 75(1):35-41. PubMed ID: 9614854
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
    Miao HQ, Ishai-Michaeli R, Peretz T, Vlodavsky I.
    J Cell Physiol; 1995 Sep 15; 164(3):482-90. PubMed ID: 7650058
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
    Takano S, Gately S, Neville ME, Herblin WF, Gross JL, Engelhard H, Perricone M, Eidsvoog K, Brem S.
    Cancer Res; 1994 May 15; 54(10):2654-60. PubMed ID: 7513254
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen gel matrix culture.
    Toda S, Nishimura T, Yamada S, Koike N, Yonemitsu N, Watanabe K, Matsumura S, Gärtner R, Sugihara H.
    J Pathol; 1999 Aug 15; 188(4):415-22. PubMed ID: 10440753
    [Abstract] [Full Text] [Related]

  • 12. Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans.
    Reis RC, Schuppan D, Barreto AC, Bauer M, Bork JP, Hassler G, Coelho-Sampaio T.
    Biochem Biophys Res Commun; 2005 Aug 05; 333(3):976-83. PubMed ID: 15985216
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of bFGF/EGF-dependent endothelial cell proliferation by the hyaluronan-binding protease from human plasma.
    Etscheid M, Beer N, Kress JA, Seitz R, Dodt J.
    Eur J Cell Biol; 2004 Jan 05; 82(12):597-604. PubMed ID: 15035435
    [Abstract] [Full Text] [Related]

  • 17. Quantitative characterization of high- and low-affinity binding sites for basic fibroblast growth factor on trabecular cells of the eye.
    Tripathi RC, Borisuth NS, Li J, Tripathi AJ, Tripathi BJ.
    Exp Eye Res; 1997 Mar 05; 64(3):335-41. PubMed ID: 9196384
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modulation of the epidermal growth factor receptor by basic fibroblast growth factor.
    Maher PA.
    J Cell Physiol; 1993 Feb 05; 154(2):350-8. PubMed ID: 8425916
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.